These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9443488)

  • 21. White matter integrity in premanifest and early Huntington's disease is related to caudate loss and disease progression.
    Novak MJ; Seunarine KK; Gibbard CR; Hobbs NZ; Scahill RI; Clark CA; Tabrizi SJ
    Cortex; 2014 Mar; 52():98-112. PubMed ID: 24405816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Joint effects of gray matter atrophy and altered functional connectivity on cognitive deficits in amnestic mild cognitive impairment patients.
    Xie C; Bai F; Yuan B; Yu H; Shi Y; Yuan Y; Wu D; Zhang ZS; Zhang ZJ
    Psychol Med; 2015 Jul; 45(9):1799-810. PubMed ID: 25511078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease.
    Bartzokis G; Tishler TA
    Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):821-33. PubMed ID: 10875443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strategic role of frontal white matter tracts in vascular cognitive impairment: a voxel-based lesion-symptom mapping study in CADASIL.
    Duering M; Zieren N; Hervé D; Jouvent E; Reyes S; Peters N; Pachai C; Opherk C; Chabriat H; Dichgans M
    Brain; 2011 Aug; 134(Pt 8):2366-75. PubMed ID: 21764819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural and metabolic brain correlates of apathy in Huntington's disease.
    Martínez-Horta S; Perez-Perez J; Sampedro F; Pagonabarraga J; Horta-Barba A; Carceller-Sindreu M; Gomez-Anson B; Lozano-Martinez GA; Lopez-Mora DA; Camacho V; Fernández-León A; Carrió I; Kulisevsky J
    Mov Disord; 2018 Jul; 33(7):1151-1159. PubMed ID: 29676484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat.
    Ruocco HH; Bonilha L; Li LM; Lopes-Cendes I; Cendes F
    J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):130-5. PubMed ID: 17615168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemical pathology in brain white matter of recently detoxified alcoholics: a 1H magnetic resonance spectroscopy investigation of alcohol-associated frontal lobe injury.
    Schweinsburg BC; Taylor MJ; Alhassoon OM; Videen JS; Brown GG; Patterson TL; Berger F; Grant I
    Alcohol Clin Exp Res; 2001 Jun; 25(6):924-34. PubMed ID: 11410730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compromised pontocerebellar and cerebellothalamocortical systems: speculations on their contributions to cognitive and motor impairment in nonamnesic alcoholism.
    Sullivan EV
    Alcohol Clin Exp Res; 2003 Sep; 27(9):1409-19. PubMed ID: 14506401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
    Tabrizi SJ; Reilmann R; Roos RA; Durr A; Leavitt B; Owen G; Jones R; Johnson H; Craufurd D; Hicks SL; Kennard C; Landwehrmeyer B; Stout JC; Borowsky B; Scahill RI; Frost C; Langbehn DR;
    Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Grey matter volume loss is associated with specific clinical motor signs in Huntington's disease.
    Coppen EM; Jacobs M; van den Berg-Huysmans AA; van der Grond J; Roos RAC
    Parkinsonism Relat Disord; 2018 Jan; 46():56-61. PubMed ID: 29128164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progressive gray matter atrophy in lacunar patients with vascular mild cognitive impairment.
    Grau-Olivares M; Arboix A; Junqué C; Arenaza-Urquijo EM; Rovira M; Bartrés-Faz D
    Cerebrovasc Dis; 2010; 30(2):157-66. PubMed ID: 20551631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal structural and molecular neuroimaging in agrammatic primary progressive aphasia.
    Tetzloff KA; Duffy JR; Clark HM; Strand EA; Machulda MM; Schwarz CG; Senjem ML; Reid RI; Spychalla AJ; Tosakulwong N; Lowe VJ; Jack CR; Josephs KA; Whitwell JL
    Brain; 2018 Jan; 141(1):302-317. PubMed ID: 29228180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroimaging determinants of cognitive performances in stroke associated with small vessel disease.
    Mok V; Chang C; Wong A; Lam WW; Richards PS; Wong KT; Wong KS
    J Neuroimaging; 2005 Apr; 15(2):129-37. PubMed ID: 15746224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single photon emission computed tomographic blood flow and magnetic resonance volume imaging of basal ganglia in Huntington's disease.
    Harris GJ; Aylward EH; Peyser CE; Pearlson GD; Brandt J; Roberts-Twillie JV; Barta PE; Folstein SE
    Arch Neurol; 1996 Apr; 53(4):316-24. PubMed ID: 8929153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral structure on MRI, Part II: Specific changes in Alzheimer's and Huntington's diseases.
    Jernigan TL; Salmon DP; Butters N; Hesselink JR
    Biol Psychiatry; 1991 Jan; 29(1):68-81. PubMed ID: 1825793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
    Semkovska M; Bédard MA; Stip E
    Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developmental trajectories of the fronto-temporal lobes from infancy to early adulthood in healthy individuals.
    Tanaka C; Matsui M; Uematsu A; Noguchi K; Miyawaki T
    Dev Neurosci; 2012; 34(6):477-87. PubMed ID: 23257954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smaller frontal gray matter volume in postmortem schizophrenic brains.
    Selemon LD; Kleinman JE; Herman MM; Goldman-Rakic PS
    Am J Psychiatry; 2002 Dec; 159(12):1983-91. PubMed ID: 12450946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. White matter volume and cognitive dysfunction in early Huntington's disease.
    Beglinger LJ; Nopoulos PC; Jorge RE; Langbehn DR; Mikos AE; Moser DJ; Duff K; Robinson RG; Paulsen JS
    Cogn Behav Neurol; 2005 Jun; 18(2):102-7. PubMed ID: 15970729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microstructural white matter abnormality and frontal cognitive dysfunctions in juvenile myoclonic epilepsy.
    Kim JH; Suh SI; Park SY; Seo WK; Koh I; Koh SB; Seol HY
    Epilepsia; 2012 Aug; 53(8):1371-8. PubMed ID: 22708960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.